Serono "neutral," estimates raised
newratings.com - USA
... by Serono is likely to include late-stage pipeline products, given the company’s financial dependence on Rebif and potential competition from Tysabri in the ...

Earnings Preview:Biogen Idec
BusinessWeek - USA
... resume sales of multiple sclerosis drug Tysabri, however the agency delayed making a final decision until June on the drug, which was pulled from the market ...